Table 1. Demographics by Study Group.
| ALL (No. = 125) | 7.5 mcg (No. = 25) | 15 mcg (No. = 25) | 45 mcg (No. = 25) | 90 mcg (No. = 25) | Placebo (No. = 25) | |
| Gender – No. (%) 1 | ||||||
| Male | 61 (49) | 10 (40) | 11 (44) | 14 (56) | 13 (52) | 13 (52) |
| Female | 64 (51) | 15 (60) | 14 (56) | 11 (44) | 12 (48) | 12 (48) |
| Race – No. (%) 2 | ||||||
| American Indian/Alaskan Native | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 14 (11) | 4 (16) | 2 (8) | 2 (8) | 4 (16) | 2 (8) |
| Hawaiian/Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 |
| Black/African American | 10 (8) | 2 (8) | 0 | 5 (20) | 1 (4) | 2 (8) |
| White | 94 (75) | 19 (76) | 23 (92) | 15 (60) | 18 (72) | 19 (76) |
| Multi-Racial | 6 (5) | 0 | 0 | 2 (8) | 2 (8) | 2 (8) |
| Other/Unknown | 1 (1) | 0 | 0 | 1 (4) | 0 | 0 |
| Age in Years 3 | ||||||
| Mean (STD) | 28.1 (5.0) | 29.1 (5.5) | 29.6 (5.5) | 27.8 (4.9) | 28.2 (4.8) | 25.7 (3.7) |
| Median | 26.4 | 28.8 | 28.4 | 26.1 | 28.0 | 25.2 |
| Min,Max | (18, 40) | (22, 40) | (18, 40) | (21, 38) | (19, 38) | (20, 38) |
1
Male vs. nonmale frequency by dosage, chi-square 1.73, p = .785.
2
White vs. nonwhite frequency by dosage, chi-square 7.04, p = .134.
3
Age vs. dosage, Anova, p>.05.